Skip to main content
Top
Published in: Endocrine 1/2018

01-01-2018 | Endocrine Methods and Techniques

Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cells

Authors: Aurora Aiello, Maria Francesca Cassarino, Simona Nanni, Antonella Sesta, Francesco Ferraú, Claudio Grassi, Marco Losa, Francesco Trimarchi, Alfredo Pontecorvi, Salvatore Cannavò, Francesca Pecori Giraldi, Antonella Farsetti

Published in: Endocrine | Issue 1/2018

Login to get access

Abstract

Purpose

The aim of this study was to generate immortalized human anterior pituitary adenoma cells. Reliable cell models for the study of human pituitary adenomas are as yet lacking and studies performed so far used repeated passaging of freshly excised adenomas, with the attendant limitations due to limited survival in culture, early senescence, and poor reproducibility.

Methods & Results

We devised a technique based upon repeated co-transfections of two retroviral vectors, one carrying the catalytic subunit of human telomerase, hTERT, the other SV40 large T antigen. This approach extended the lifespan of cells derived from a human growth hormone-secreting adenoma up to 18 months while retaining morphology of primary cells, growth hormone synthesis and growth hormone secretion.

Conclusions

Our attempt represents the first demonstration of successful lifespan extension of human growth hormone-secreting pituitary adenoma cells via co-transfection of hTERT and SV40T and paves the way to future attempts to obtain stable cell lines.
Literature
1.
go back to reference K. Inoue, M. Hattori, T. Sakai et al., Establishment of a series of pituitary clonal cell lines differing in morphology, hormone secretion, and response to estrogen. Endocrinology 126, 2313–2320 (1990)CrossRefPubMed K. Inoue, M. Hattori, T. Sakai et al., Establishment of a series of pituitary clonal cell lines differing in morphology, hormone secretion, and response to estrogen. Endocrinology 126, 2313–2320 (1990)CrossRefPubMed
2.
go back to reference M.J. Reymond, D.D. Nansel, G.H. Burrows, W.B. Neaves, J.C. Porter, A new clonal strain of rat pituitary tumour cells: a model for non-regulated secretion of prolactin. Acta Endocrinol. 106, 459–470 (1984)PubMed M.J. Reymond, D.D. Nansel, G.H. Burrows, W.B. Neaves, J.C. Porter, A new clonal strain of rat pituitary tumour cells: a model for non-regulated secretion of prolactin. Acta Endocrinol. 106, 459–470 (1984)PubMed
3.
go back to reference J. Furth, E.L. Gadsen, A.C. Upton, ACTH secreting transplantable pituitary tumors. Proc. Soc. Exp. Biol. Med. 84, 253–254 (1953)CrossRefPubMed J. Furth, E.L. Gadsen, A.C. Upton, ACTH secreting transplantable pituitary tumors. Proc. Soc. Exp. Biol. Med. 84, 253–254 (1953)CrossRefPubMed
4.
go back to reference D. Lew, H. Brady, K. Klausing et al., GHF-1-promoter-targeted immortalization of a somatotropic progenitor cell results in dwarfism in transgenic mice. Genes. Dev. 7, 683–693 (1993)CrossRefPubMed D. Lew, H. Brady, K. Klausing et al., GHF-1-promoter-targeted immortalization of a somatotropic progenitor cell results in dwarfism in transgenic mice. Genes. Dev. 7, 683–693 (1993)CrossRefPubMed
5.
go back to reference E.T. Alarid, J.J. Windle, D.B. Whyte, P.L. Mellon, Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice. Development 122, 3319–3329 (1996)PubMed E.T. Alarid, J.J. Windle, D.B. Whyte, P.L. Mellon, Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice. Development 122, 3319–3329 (1996)PubMed
6.
go back to reference Y. Kokubu, M. Asashima, A. Kurisaki, Establishment and culture optimization of a new type of pituitary immortalized cell line. Biochem. Biophys. Res. Commun. 463, 1218–1224 (2015)CrossRefPubMed Y. Kokubu, M. Asashima, A. Kurisaki, Establishment and culture optimization of a new type of pituitary immortalized cell line. Biochem. Biophys. Res. Commun. 463, 1218–1224 (2015)CrossRefPubMed
7.
go back to reference G.L. Kim, X. Wang, J.A. Chalmers et al., Generation of immortal cell lines from the adult pituitary: role of cAMP on differentiation of SOX2-expressing progenitor cells to mature gonadotropes. PloS. ONE. 6, e27799 (2011)CrossRefPubMedPubMedCentral G.L. Kim, X. Wang, J.A. Chalmers et al., Generation of immortal cell lines from the adult pituitary: role of cAMP on differentiation of SOX2-expressing progenitor cells to mature gonadotropes. PloS. ONE. 6, e27799 (2011)CrossRefPubMedPubMedCentral
8.
go back to reference D. Avtanski, H.J. Novaira, S. Wu et al., Both estrogen receptor alpha and beta stimulate pituitary GH gene expression. Mol. Endocrinol. 28, 40–52 (2014)CrossRefPubMed D. Avtanski, H.J. Novaira, S. Wu et al., Both estrogen receptor alpha and beta stimulate pituitary GH gene expression. Mol. Endocrinol. 28, 40–52 (2014)CrossRefPubMed
9.
go back to reference J.C. Stone, J. Clark, R. Cuneo, A.W. Russell, S.A. Doi, Estrogen and selective estrogen receptor modulators (SERMs) for the treatment of acromegaly: a meta-analysis of published observational studies. Pituitary 17, 284–295 (2014)CrossRefPubMed J.C. Stone, J. Clark, R. Cuneo, A.W. Russell, S.A. Doi, Estrogen and selective estrogen receptor modulators (SERMs) for the treatment of acromegaly: a meta-analysis of published observational studies. Pituitary 17, 284–295 (2014)CrossRefPubMed
10.
go back to reference A.P. Heaney, F. Manory, W.H. Hong, S. Melmed, Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas. Nature. Med. 8, 1281–1287 (2002)CrossRefPubMed A.P. Heaney, F. Manory, W.H. Hong, S. Melmed, Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas. Nature. Med. 8, 1281–1287 (2002)CrossRefPubMed
11.
go back to reference F. Pecori Giraldi, C. Scaroni, E. Arvat et al., Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing’s disease. Clin. Endocrinol. 64, 219–224 (2006)CrossRef F. Pecori Giraldi, C. Scaroni, E. Arvat et al., Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing’s disease. Clin. Endocrinol. 64, 219–224 (2006)CrossRef
12.
go back to reference F. Pecori Giraldi, S. Pesce, P. Maroni et al., Inhibitory effect of preproTRH(178-199) on ACTH secretion by human corticotrope tumours. J. Neuroendocrinol. 22, 294–300 (2010)CrossRefPubMed F. Pecori Giraldi, S. Pesce, P. Maroni et al., Inhibitory effect of preproTRH(178-199) on ACTH secretion by human corticotrope tumours. J. Neuroendocrinol. 22, 294–300 (2010)CrossRefPubMed
13.
go back to reference S. Nanni, V. Benvenuti, A. Grasselli et al., Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. J. Clin. Invest. 119, 1093–1108 (2009)CrossRefPubMedPubMedCentral S. Nanni, V. Benvenuti, A. Grasselli et al., Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. J. Clin. Invest. 119, 1093–1108 (2009)CrossRefPubMedPubMedCentral
14.
go back to reference A.H. Tashjian Jr., Y. Yasumura, L. Levine, G.H. Sato, M.L. Parker, Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. Endocrinology 82, 342–352 (1968)CrossRefPubMed A.H. Tashjian Jr., Y. Yasumura, L. Levine, G.H. Sato, M.L. Parker, Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. Endocrinology 82, 342–352 (1968)CrossRefPubMed
15.
go back to reference P. Thomas, P.L. Mellon, J. Turgeon, D.W. Waring, The L beta T2 clonal gonadotrope: a model for single cell studies of endocrine cell secretion. Endocrinology 137, 2979–2989 (1996)CrossRefPubMed P. Thomas, P.L. Mellon, J. Turgeon, D.W. Waring, The L beta T2 clonal gonadotrope: a model for single cell studies of endocrine cell secretion. Endocrinology 137, 2979–2989 (1996)CrossRefPubMed
16.
go back to reference D. Sizova, Y. Ho, N.E. Cooke, S.A. Liebhaber, T-antigen transformation of pituitary cells captures three novel cell lines in the Pit-1 lineage. Mol. Endocrinol. 24, 2232–2240 (2010)CrossRefPubMedPubMedCentral D. Sizova, Y. Ho, N.E. Cooke, S.A. Liebhaber, T-antigen transformation of pituitary cells captures three novel cell lines in the Pit-1 lineage. Mol. Endocrinol. 24, 2232–2240 (2010)CrossRefPubMedPubMedCentral
17.
go back to reference J. Ham, J. Webster, J.A. Bond et al., Immortalized human pituitary cells express glycoprotein alpha-subunit and thyrotropin beta (TSH beta). J. Clin. Endocrinol. Metab. 83, 1598–1603 (1998)PubMed J. Ham, J. Webster, J.A. Bond et al., Immortalized human pituitary cells express glycoprotein alpha-subunit and thyrotropin beta (TSH beta). J. Clin. Endocrinol. Metab. 83, 1598–1603 (1998)PubMed
18.
go back to reference P. Chomczynski, P.A. Soszynski, L.A. Frohman, Stimulatory effect of thyroid hormone on growth hormone gene expression in a human pituitary cell line. J. Clin. Endocrinol. Metab. 77, 281–285 (1993)PubMed P. Chomczynski, P.A. Soszynski, L.A. Frohman, Stimulatory effect of thyroid hormone on growth hormone gene expression in a human pituitary cell line. J. Clin. Endocrinol. Metab. 77, 281–285 (1993)PubMed
19.
go back to reference J.H. Wyche, W.D. Noteboom, Growth regulation of cultured human pituitary cells by steroidal and nonsteroidal compounds in defined medium. Endocrinology 104, 1765–1773 (1979)CrossRefPubMed J.H. Wyche, W.D. Noteboom, Growth regulation of cultured human pituitary cells by steroidal and nonsteroidal compounds in defined medium. Endocrinology 104, 1765–1773 (1979)CrossRefPubMed
20.
go back to reference Y. Kikuchi, K. Seki, E. Momose et al., Establishment and characterization of a new human cultured cell line from a prolactin-secreting pituitary adenoma. Cancer Res. 45, 5722–5727 (1985)PubMed Y. Kikuchi, K. Seki, E. Momose et al., Establishment and characterization of a new human cultured cell line from a prolactin-secreting pituitary adenoma. Cancer Res. 45, 5722–5727 (1985)PubMed
21.
go back to reference D.C. Danila, X. Zhang, Y. Zhou et al., A human pituitary tumor-derived folliculostellate cell line. J. Clin. Endocrinol. Metab. 85, 1180–1187 (2000)PubMed D.C. Danila, X. Zhang, Y. Zhou et al., A human pituitary tumor-derived folliculostellate cell line. J. Clin. Endocrinol. Metab. 85, 1180–1187 (2000)PubMed
22.
go back to reference L. Jin, E. Kulig, X. Qian et al., A human pituitary adenoma cell line prolfierates and maintains some differentiated fucntions following expression of SV40 large T-antigen. Endocr. Pathol. 9, 169–184 (1998)CrossRef L. Jin, E. Kulig, X. Qian et al., A human pituitary adenoma cell line prolfierates and maintains some differentiated fucntions following expression of SV40 large T-antigen. Endocr. Pathol. 9, 169–184 (1998)CrossRef
23.
go back to reference M.B.S. Lopes, Growth hormone-secreting adenomas: pathology and cell biology. Neurosurg. Focus. 29, E2–E8 (2010)CrossRefPubMed M.B.S. Lopes, Growth hormone-secreting adenomas: pathology and cell biology. Neurosurg. Focus. 29, E2–E8 (2010)CrossRefPubMed
Metadata
Title
Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cells
Authors
Aurora Aiello
Maria Francesca Cassarino
Simona Nanni
Antonella Sesta
Francesco Ferraú
Claudio Grassi
Marco Losa
Francesco Trimarchi
Alfredo Pontecorvi
Salvatore Cannavò
Francesca Pecori Giraldi
Antonella Farsetti
Publication date
01-01-2018
Publisher
Springer US
Published in
Endocrine / Issue 1/2018
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1305-6

Other articles of this Issue 1/2018

Endocrine 1/2018 Go to the issue